Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Nintedanib for progressive fibrosing interstitial lung disease	Nintedanib (Vargatef; Ofev; nintedanib esilate)	Progressive fibrosing interstitial lung disease (PF-ILD)	Respiratory System	2019	View \| Download
Nicardipine for treating aneurysmal subarachnoid haemorrhage	Nicardipine (NicaPlant; nicardipine hydrochloride)	Aneurysmal subarachnoid haemorrhage	Cardiovascular System	2022	View \| Download
Neuro-Cells for treating traumatic spinal cord injury	Neuro-Cells	Spinal cord injury	Musculoskeletal System	2024	View \| Download
Netarsudil plus latanoprost (Roclatan) for glaucoma or ocular hypertension	Roclatan (Roclanda; PG324) (fixed dose combination: Netarsudil mesylate; Latanoprost)	Glaucoma , Ocular hypertension	Ophthalmology	2017	View \| Download
Nerinetide for acute ischaemic stroke	Nerinetide (NA-1)	Ischaemic stroke	Cardiovascular System	2019	View \| Download
Neridronic Acid (Nerixia) for Complex Regional Pain Syndrome	Neridronic acid	Complex regional pain syndrome (CRPS)	Neurology	2017	View \| Download
NEOD001 for amyloid light-chain (AL) amyloidosis	Birtamimab (NEOD001)	Amyloidosis	Endocrine Nutritional and Metabolic Disorders	2017	View \| Download
Neoadjuvant nivolumab with gemcitabine and cisplatin followed by adjuvant nivolumab for previously-untreated muscle-invasive bladder cancer	Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Bladder cancer	Urological Cancer	2023	View \| Download
Neoadjuvant atezolizumab with chemotherapy followed by adjuvant atezolizumab for treating triple-negative breast cancer	Atezolizumab (Tecentriq; MPDL3280A) , Chemotherapy	Breast cancer	Breast Cancer	2022	View \| Download
Nemolizumab for treating atopic dermatitis and prurigo nodularis	Nemolizumab	Atopic dermatitis , Prurigo nodularis (PN)	Dermatology	2022	View \| Download